Douglas Kyle Hogarth to Protein Kinase Inhibitors
This is a "connection" page, showing publications Douglas Kyle Hogarth has written about Protein Kinase Inhibitors.
Connection Strength
0.034
-
Prognostic performance of proteomic testing in advanced non-small cell lung cancer: a systematic literature review and meta-analysis. Curr Med Res Opin. 2020 09; 36(9):1497-1505.
Score: 0.034